Interim Condensed Consolidated Statement of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenues [Abstract]
Total revenue	$ 29,465	$ 40,981
Total cost of sales	26,095	29,666
Gross profit	3,370	11,315
Expenses
Sales and marketing	6,670	7,408
General and administrative	7,241	7,825
Operations support	2,297	2,532
Technology and development	1,935	2,165
Stock-based compensation	1,094	461
Total operating expenses	19,237	20,391
Operating loss	(15,867)	(9,076)
Government subsidies	4,068
Foreign exchange gain (loss)	(180)	2,319
Interest income	19	138
Interest expense	(500)	(35)
Non Operating (income) loss	3,407	2,422
Loss before tax	(12,460)	(6,654)
Income taxes
Current tax expense (recovery)		(581)
Deferred tax expense (recovery)	39	(745)
Income tax expense	39	(1,326)
Net loss	$ (12,499)	$ (5,328)
Loss per share
Basic and diluted loss per share	$ (0.15)	$ (0.06)
Weighted average number of shares outstanding (in thousands)
Basic and diluted	84,681	84,681
Interim Condensed Consolidated Statement of Comprehensive Loss
Loss for the period	$ (12,499)	$ (5,328)
Exchange differences on translation of foreign operations	605	(6,768)
Comprehensive loss for the period	(11,894)	(12,096)
Product [Member]
Revenues [Abstract]
Total revenue	28,542	40,299
Total cost of sales	23,551	27,290
Service [Member]
Revenues [Abstract]
Total revenue	923	682
Total cost of sales	788	366
Under-utilized Capacity [Member]
Revenues [Abstract]
Total cost of sales	$ 1,756	$ 2,010